BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9203634)

  • 1. Cell-specific, promoter-dependent mineralocorticoid agonist activity of spironolactone.
    Massaad C; Lombès M; Aggerbeck M; Rafestin-Oblin ME; Barouki R
    Mol Pharmacol; 1997 Feb; 51(2):285-92. PubMed ID: 9203634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aldosterone and related steroids on LPS-induced increased expression of inducible NOS in rat aortic smooth muscle cells.
    Godfrey V; Martin AL; Struthers AD; Lyles GA
    Br J Pharmacol; 2011 Dec; 164(8):2003-14. PubMed ID: 21649641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoter.
    Couette B; Marsaud V; Baulieu EE; Richard-Foy H; Rafestin-Oblin ME
    Endocrinology; 1992 Jan; 130(1):430-6. PubMed ID: 1309341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes.
    Penfornis P; Viengchareun S; Le Menuet D; Cluzeaud F; Zennaro MC; Lombès M
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E386-94. PubMed ID: 10913039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human mineralocorticoid receptor function by protein kinase A.
    Massaad C; Houard N; Lombès M; Barouki R
    Mol Endocrinol; 1999 Jan; 13(1):57-65. PubMed ID: 9892012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibition, but not a mineralocorticoid receptor antagonist spironolactone, attenuates atypical transcription by an activating mutant MR (MRS 810L ).
    Kang SH; Lee HA; Lee E; Kim M; Kim I
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):995-1003. PubMed ID: 27362706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction.
    Mihailidou AS; Loan Le TY; Mardini M; Funder JW
    Hypertension; 2009 Dec; 54(6):1306-12. PubMed ID: 19841288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin in rat renal fibroblasts: functional properties and transcriptional regulation by aldosterone.
    Irita J; Okura T; Kurata M; Miyoshi K; Fukuoka T; Higaki J
    Hypertension; 2008 Feb; 51(2):507-13. PubMed ID: 18158341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of spironolactone on endothelial cell apoptosis.
    Williams TA; Verhovez A; Milan A; Veglio F; Mulatero P
    Endocrinology; 2006 May; 147(5):2496-505. PubMed ID: 16497808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituent.
    Souque A; Fagart J; Couette B; Davioud E; Sobrio F; Marquet A; Rafestin-Oblin ME
    Endocrinology; 1995 Dec; 136(12):5651-8. PubMed ID: 7588320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter.
    Grossmann C; Krug AW; Freudinger R; Mildenberger S; Voelker K; Gekle M
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1790-800. PubMed ID: 17311890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human mineralocorticoid receptor gene 5'-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms.
    Zennaro MC; Le Menuet D; Lombès M
    Mol Endocrinol; 1996 Dec; 10(12):1549-60. PubMed ID: 8961265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-chronic stimulation of glucocorticoid receptor impairs and mineralocorticoid receptor protects cytosolic Ca2+ responses to glucose in pancreatic beta-cells.
    Koizumi M; Yada T
    J Endocrinol; 2008 May; 197(2):221-9. PubMed ID: 18434352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists.
    Schupp N; Queisser N; Wolf M; Kolkhof P; Bärfacker L; Schäfer S; Heidland A; Stopper H
    Horm Metab Res; 2010 Jun; 42(6):458-65. PubMed ID: 20094972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner.
    Bunda S; Liu P; Wang Y; Liu K; Hinek A
    Am J Pathol; 2007 Sep; 171(3):809-19. PubMed ID: 17724138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid regulation of transcription of transfected mouse mammary tumor virus DNA in cultured kidney cells.
    Cato AC; Weinmann J
    J Cell Biol; 1988 Jun; 106(6):2119-25. PubMed ID: 2838493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of the steroid regulation of transmitter choice in cultured rat sympathetic ganglia.
    McLennan IS; Hill CE; Hendry IA
    Aust J Exp Biol Med Sci; 1984 Oct; 62 ( Pt 5)():627-39. PubMed ID: 6152534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid and mineralocorticoid receptors regulate paracellular permeability in a primary cultured gill epithelium.
    Kelly SP; Chasiotis H
    J Exp Biol; 2011 Jul; 214(Pt 14):2308-18. PubMed ID: 21697422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SC 25152: a potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone.
    Cutler GB; Sauer MA; Loriaux DL
    J Pharmacol Exp Ther; 1979 Apr; 209(1):144-6. PubMed ID: 430374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.